Scholars Central

Research articlePublished 31 Jul 2023

A Review of the Current Status of Anthrax Medical Countermeasures

Authors: Robert V House

DynPort Vaccine Company LLC, Frederick, Maryland, USA

Journal of Bioterrorism & Biodefense

Volume 14 · Issue 4 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Anthrax, the disease resulting from infection with the zoonotic bacterium Bacillus anthracis, has a high potential for use as an agent of biological terrorism and warfare, and has in fact been used for both. Given its relative high mortality rate in untreated humans, effective medical treatments and prophylactics are essential. This brief review will summarize the current state of medical countermeasures (MCM) for treating individuals exposed to anthrax as well as preventing the disease from manifesting.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioterrorism & Biodefense.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioterrorism & Biodefense
  • SubjectImmunology & Microbiology
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Robert V House”